Melbourne Neuropsychiatry Centre

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages) The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources: "Melbourne Neuropsychiatry Centre" – news · newspapers · books · scholar · JSTOR (March 2019) (Learn how and when to remove this template message) This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources: "Melbourne Neuropsychiatry Centre" – news · newspapers · books · scholar · JSTOR (March 2019) This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. Please help improve it by replacing them with more appropriate citations to reliable, independent, third-party sources. (March 2019) (Learn how and when to remove this template message) (Learn how and when to remove this template message)

The Melbourne Neuropsychiatry Centre (MNC), is a joint centre of University of Melbourne and Melbourne Health in Australia. It brings together clinical and research teams at Sunshine and Royal Melbourne Hospitals, with a dedicated brain imaging archive and analysis laboratory located at the University's Parkville campus.

The MNC was established in 2004 with the appointment of Christos Pantelis as Foundation Professor in Neuropsychiatry at The University of Melbourne. Since that time, MNC has established its reputation as one of the most productive psychiatric research centres in Australia. The team at MNC currently consists of both academic and professional staff. At any given time MNC supports over 30 individuals who work with the research streams at the Alan Gilbert Building as stipend funded PhD students, Masters and Honours students, and international research fellows.

The MNC has established an international reputation in the areas of cognition and neuroimaging in schizophrenia with several important publications in high-profile international psychiatry, neurology and radiology journals. MNC has maintained a core research focus on understanding the neurobiology of psychosis and other neurodevelopment disorders (including autism spectrum disorders), following on from its seminal work identifying progressive changes at transition to a psychotic illness (Pantelis et al., Lancet, 2003). It has also developed core overlapping research interests in the area of epilepsy and neurodegenerative disorders (Velakoulis et al.); depression and anxiety (Harrison et al., Whittle et al.); advanced brain network science (Zalesky et al.) and psychiatric genetics and genomics (Bousman et al.). The MNC aims to ensure that people suffering from neuropsychiatric disorders benefit from cutting edge research that will improve management and treatment outcomes.

External links

• Melbourne Neuropsychiatry Centre website

This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources. Find sources: "Melbourne Neuropsychiatry Centre" – news · newspapers · books · scholar · JSTOR (March 2019) (Learn how and when to remove this template message)

This Melbourne-related article is a stub. You can help Wikipedia by expanding it.

• v
• t
• e

This psychiatry-related article is a stub. You can help Wikipedia by expanding it.

• v
• t
• e